Download Leukaemia Section t(12;20)(q15;q11.2) Atlas of Genetics and Cytogenetics in Oncology and Haematology

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Gene therapy of the human retina wikipedia , lookup

Neuronal ceroid lipofuscinosis wikipedia , lookup

Genetic code wikipedia , lookup

Gene expression programming wikipedia , lookup

History of genetic engineering wikipedia , lookup

Protein moonlighting wikipedia , lookup

Minimal genome wikipedia , lookup

Site-specific recombinase technology wikipedia , lookup

Cancer epigenetics wikipedia , lookup

Genome evolution wikipedia , lookup

Expanded genetic code wikipedia , lookup

Genome (book) wikipedia , lookup

Gene wikipedia , lookup

Epigenetics of neurodegenerative diseases wikipedia , lookup

Vectors in gene therapy wikipedia , lookup

Microevolution wikipedia , lookup

Point mutation wikipedia , lookup

Epigenetics of human development wikipedia , lookup

Polycomb Group Proteins and Cancer wikipedia , lookup

Nutriepigenomics wikipedia , lookup

Designer baby wikipedia , lookup

Gene expression profiling wikipedia , lookup

Medical genetics wikipedia , lookup

Therapeutic gene modulation wikipedia , lookup

Mir-92 microRNA precursor family wikipedia , lookup

Artificial gene synthesis wikipedia , lookup

RNA-Seq wikipedia , lookup

NEDD9 wikipedia , lookup

Transcript
Atlas of Genetics and Cytogenetics
in Oncology and Haematology
OPEN ACCESS JOURNAL AT INIST-CNRS
Leukaemia Section
Short Communication
t(12;20)(q15;q11.2)
Jean Loup Huret
Genetics, Dept Medical Information, UMR 8125 CNRS, University of Poitiers, CHU Poitiers Hospital, F86021 Poitiers, France (JLH)
Published in Atlas Database: May 2005
Online updated version: http://AtlasGeneticsOncology.org/Anomalies/t1220q15q11ID1393.html
DOI: 10.4267/2042/38228
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 2.0 France Licence.
© 2005 Atlas of Genetics and Cytogenetics in Oncology and Haematology
Clinics and pathology
Result of the chromosomal
anomaly
Disease
Myelodysplastic/myeloproliferative
syndrome,
unclassifiable.
Epidemiology
Only 1 case to date: a 67 yr old female patient without
BCR-ABL rearrangement.
Cytology
Basophilia (10%) and bone marrow fibrosis.
Cytogenetics
Additional anomaly: add(6).
Prognosis
Survival: 20 mths+; largely asymptomatic.
Hybrid gene
Description
HMGA2 exon 3 spliced to intron 3 of the gene and an
alternative product with exon 2 spliced to intron 2.
Fusion protein
Description
Ttruncated HMGA2 (normal exons 1 to 3 followed by
7 amino acids from intron 3 and normal exons 1-2plus
15 amino acids from intron 2); ectopic expression of
HMGA2.
References
Genes involved and proteins
Odero MD, Grand FH, Iqbal S, Ross F, Roman JP, Vizmanos
JL, Andrieux J, Laï JL, Calasanz MJ, Cross NC. Disruption and
aberrant expression of HMGA2 as a consequence of diverse
chromosomal translocations in myeloid malignancies.
Leukemia. 2005 Feb;19(2):245-52
HGMA2
Location
12q15
Protein
Probable role in regulation of cell proliferation
(transcriptional regulation of cell cycle and DNA repair
genes.
Atlas Genet Cytogenet Oncol Haematol. 2005; 9(3)
This article should be referenced as such:
Huret JL. t(12;20)(q15;q11.2). Atlas Genet Cytogenet Oncol
Haematol. 2005; 9(3):249.
249